Growth Metrics

Repligen (RGEN) EPS (Basic) (2016 - 2025)

Repligen (RGEN) has disclosed EPS (Basic) for 16 consecutive years, with $0.24 as the latest value for Q4 2025.

  • On a quarterly basis, EPS (Basic) rose 139.34% to $0.24 in Q4 2025 year-over-year; TTM through Dec 2025 was $0.87, a 289.13% increase, with the full-year FY2025 number at $0.87, up 289.13% from a year prior.
  • EPS (Basic) was $0.24 for Q4 2025 at Repligen, down from $0.26 in the prior quarter.
  • In the past five years, EPS (Basic) ranged from a high of $0.9 in Q2 2022 to a low of -$0.61 in Q4 2024.
  • A 5-year average of $0.32 and a median of $0.29 in 2023 define the central range for EPS (Basic).
  • Peak YoY movement for EPS (Basic): plummeted 164.37% in 2023, then skyrocketed 2700.0% in 2025.
  • Repligen's EPS (Basic) stood at $0.52 in 2021, then soared by 67.31% to $0.87 in 2022, then crashed by 164.37% to -$0.56 in 2023, then decreased by 8.93% to -$0.61 in 2024, then surged by 139.34% to $0.24 in 2025.
  • Per Business Quant, the three most recent readings for RGEN's EPS (Basic) are $0.24 (Q4 2025), $0.26 (Q3 2025), and $0.27 (Q2 2025).